Skip to content

Intracervical Anesthesia and Pain Associated With Intrauterine Contraceptive Insertion

Effect of Intracervical Anesthesia on Pain Associated With the Insertion of Levonorgestrel-releasing Intrauterine System in Nulligravida Women: a Randomized Controlled Trial

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03111342
Enrollment
300
Registered
2017-04-12
Start date
2017-06-01
Completion date
2018-08-31
Last updated
2019-08-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anesthesia, Local, IUD Insertion Complication, Pain, Acute

Keywords

Intrauterine contraception, Pain, Anesthesia, LNG-IUD, nulligravida

Brief summary

The primary aim of our study is to evaluate the effect of intracervical anesthesia on pain scores immediately following levonorgestrel-releasing intrauterine system (LNG-IUS) insertion in nulligravida women.

Detailed description

No prophylactic pharmacological intervention has proven efficacy in relieving pain during or after the insertion of levonorgestrel-releasing intrauterine system (LNG-IUS), only in reducing pain associated with the tenaculum. It is known that the nulligravida women have 3 times more chance of presenting moderate / severe pain associated to LNG-IUS placement. A previous study showed that injectable intracervical anesthesia reduced the risk of moderate/severe pain by 40%. However, the anesthetic dose was small (36 mg of lidocaine) and the study did not evaluate only nulligravida women which are potential candidates for most pain relief benefit. Thus, the primary aim of this study is to evaluate the effect of intracervical anesthesia on pain scores immediately following LNG-IUS insertion in nulligravida women.

Interventions

DRUGAnesthesia

A 2% lidocaine without vasoconstrictor injection into the cervix

PROCEDUREDry-needling

A placement of thin needle into the cervix without substance injection

Sponsors

University of Campinas, Brazil
CollaboratorOTHER
University of Sao Paulo
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Masking description

The care provider will open the randomization envelope and will do one of three possible approaches (a intracervical lidocaine injection, a intracervical dry needling or no intervention). Then, a second care provider will insert the intrauterine contraceptive (IUC) blinding for the approach of the first care provider. After IUC insertion, the latter care provider will assess the pain felt by the woman using proper scales. The woman will be also blinded to the approach used before IUC insertion.

Intervention model description

Nulligravida women will be block-randomized to one of three groups (intracervical anesthesia, intracervical dry needling or no intervention)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 45 Years
Healthy volunteers
Yes

Inclusion criteria

* Age between 18 and 45 years; * That were never pregnant before; * That wants to use LNG-IUD; * Not pregnant at the time of insertion; * No haematological disease; * That do not have signs and / or symptoms of vaginal / cervical infection.

Exclusion criteria

* Categories 3 and / or 4 for the use of LNG-IUD according to the medical eligibility criteria of the World Health Organization (WHO), users of illicit drugs and / or alcohol, allergy or contraindication to lidocaine, presence of chronic pelvic pain of any etiology, presence of cervical abnormality such as isthmus-cervical fibrosis or incompetence, surgery on the cervix, psychiatric disorders, chronic use of medications that could interfere with the pain threshold (such as antidepressants and anticonvulsants).

Design outcomes

Primary

MeasureTime frameDescription
Pain associated with LNG-IUS insertion using VASImmediately following LNG-IUS insertionTo evaluate pain scores using the visual analog scale (VAS)

Secondary

MeasureTime frameDescription
Pain associated with LNG-IUS insertion using face scaleImmediately following LNG-IUS insertionTo evaluate pain scores using faces scale of the International Association for the Study of Pain (IASP)
Pain associated with tenaculum placement using VASImmediately following tenaculum placementTo evaluate pain scores using the visual analog scale (VAS)
Pain associated with tenaculum placement using faces scaleImmediately following tenaculum placementTo evaluate pain scores using faces scale of the International Association for the Study of Pain (IASP)
Ease of IUS insertionImmediately following LNG-IUS insertionTo evaluate ease of LNG-IUS insertion rated by the provider

Countries

Brazil

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026